MPWT
KYMR icon

MassMutual Private Wealth & Trust’s Kymera Therapeutics KYMR Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-28
Closed -$2.33K – 2456
2026
Q1 		$2.33K Buy
+28
New +$2.22K ﹤0.01% 1936

Other funds holding KYMR

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

MassMutual Private Wealth & Trust's KYMR Position: Q2 2026 in Review

MassMutual Private Wealth & Trust sold out of Kymera Therapeutics (KYMR) in Q2 2026, closing a stake of 28 shares — an estimated $2.33K sold.

MassMutual Private Wealth & Trust first reported a position in KYMR in Q1 2026 and held it in 1 quarter. The position peaked at $2.33K in Q1 2026. 81 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • MassMutual Private Wealth & Trust reported no remaining Kymera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 28 Kymera Therapeutics shares in Q2 2026, an estimated $2.33K.
  • MassMutual Private Wealth & Trust first reported a position in Kymera Therapeutics in Q1 2026 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Kymera Therapeutics position peaked at $2.33K in Q1 2026.
  • 81 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.